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Identification of two novel equine papillomavirus sequences
suggests three genera in one cluster
Abstract
The number of recognized papillomavirus (PV) species and potential PV genera has dramatically been
increasing throughout the past decade. It seems that every host species might potentially harbour a large
set of PVs, while the PVs of each species appear to belong to only a few genera. In horses at least three
conditions beside the equine sarcoid have been described, being supposedly PV induced namely
classical equine papillomas, genital papillomas and aural plaques. We were able to identify the DNA of
novel equine PVs (EcPVs) in the two latter disorders where PV involvement had been predicted. Both
PV genomes were entirely cloned and sequenced. Both EcPV genomes, one derived from a penile
papilloma, the other derived from an ear papilloma contain the characteristic open reading frames
(ORFs) E6, E7, E1, E2, L2 and L1, a large non-coding region between the late and early region as well
as a small non-coding region between the early and the late region. The viruses were consequently
designated as EcPV2 and EcPV3. The genomes of the three equine PVs were analysed and compared
with each other and further PVs. Upon phylogenetic analyses the equine PVs group well together.
Pairwise alignment of the L1 nucleotide sequences reveals that EcPV1 shares 54.9% identities with
EcPV2 and 53.2% with EcPV3. EcPV2 and EcPV3 share 51.3% identities. As the three EcPVs share
less than 60% of nucleotide identities in L1, they may be regarded as belonging to different genera.
  !"
Identification of two novel equine papillomavirus sequences suggests three genera in one !"
cluster #"
 $"
 %"
Christian E. Langea,b,*, Kurt Toblerb, Mathias Ackermannb, Claude Favrota &"
 '"
 ("
a Dermatology Department, Clinic for Small Animal internal Medicine, Vetsuisse Faculty, )"
Winterthurerstrasse 260, CH-8057 Zurich, Switzerland  *"
b Institute of Virology, Vetsuisse Faculty, Winterthurerstrasse 266a, CH-8057 Zurich, Switzerland !+"
* Corresponding author. Tel.: +41 44 6358387; E-mail address: clange@vetclinics.uzh.ch !!"
!#"
  #"
Abstract !#"
The number of recognized papillomavirus (PV) species and potential PV genera has !$"
dramatically been increasing throughout the past decade. It seems that every host species !%"
might potentially harbour a large set of PVs, while the PVs of each species appear to belong !&"
to only a few genera.  !'"
In horses at least three conditions beside the equine sarciod have been described, being !("
supposedly PV induced namely classical equine papillomas, genital papillomas and aural !)"
plaques. We were able to identify the DNA of novel equine PVs (EcPVs) in the two latter !*"
disorders where PV involvement had been predicted. Both PV genomes were entirely cloned #+"
and sequenced. Both EcPV genomes, one derived from a penile papilloma, the other derived #!"
from an ear papilloma contain the characteristic open reading frames (ORFs) E6, E7, E1, E2, ##"
L1 and L2, a large non coding region between the late and early region as well as a small non #$"
coding region between the early and the late region. The viruses were consequently #%"
designated as EcPV2 and EcPV3. #&"
The genomes of the three equine PVs were analysed and compared with each other and #'"
further PVs. Upon phylogenetic analyses the equine PVs group well together. Pairwise #("
alignment of the L1 nucleotide sequences reveals that EcPV1 shares 54.9% identities with #)"
EcPV2 and 53.2% with EcPV3. EcPV2 and EcPV3 share 51.3% identities. As the three #*"
EcPVs share less than 60% of nucleotide identities in L1, they may be regarded as belonging $+"
to different genera. $!"
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Introduction $'"
The family of Papillomaviridae consists of a diverse variety of Papillomaviruses (PVs), $("
characterized by a small, circular, double stranded DNA genome packaged into non $)"
enveloped icosahedral viral particles (Howley and Lowy 2007). Papillomaviruses have been $*"
found to be innocuous inhabitants of the healthy skin, but are also associated with various %+"
benign and malign neoplastic diseases (Howley and Lowy 2007). While some PV types have %!"
been demonstrated to have a high oncogenic potential others are known to be less oncogenic, %#"
facultative pathogenic or believed to be apathogenic (Antonsson et al. 2000, Antonsson and %$"
Hansson 2002, Burd 2003, Muñoz et al. 2003). Consequently a categorization of primarily %%"
human PVs (HPVs) based on their transforming potential has been suggested, grouping the %&"
viruses into high-, intermediate- and low-risk PVs (Lorincz et al. 1992, Bosch et al. 1995). %'"
This grouping is partly reflected in the genomic characterization of the PVs. Viruses allocated %("
to one genus based on the nucleotide sequence of the L1 open reading frame (ORF) may share %)"
some features, but the biological behaviour can differ significantly (de Villiers et al. 2004). %*"
Expanding the knowledge about the phylogenetics and genomic organization together with &+"
the biological effects can consequently be helpful for better understanding and characterizing &!"
of the Papillomaviridae. &#"
 &$"
To date, almost 200 distinct PVs have been cloned, sequenced, and allocated to various &%"
genera. Most of the identified PV are HPVs, but the number of PVs found in lesional or &&"
nonlesional skin of animals is steadily growing. In horses, infections with papillomaviruses &'"
have been reported extensively in the context of the equine sarcoid (Bogaert et al. 2008, Nasir &("
and Campo 2008). This semi malignant neoplasia of the skin though is, as it is associated with &)"
bovine PVs, an exception, as PVs are in general believed to be species specific (Howley and &*"
Lowy 2007). Nevertheless, at least three other potentially PV associated epithelial neoplasias '+"
  %"
have been described in horses (Scott and Miller 2003). The so called classical equine viral '!"
papillomas are typically found in young horses. They occur mainly on the muzzle or lips but '#"
also less common in other locations (Scott and Miller 2003). They have a transient character '$"
and were shown to be associated with EcPV1 (O'Banion et al. 1986, Ghim et al. 2004). '%"
Infrequently occurring genital papillomas in male and female horses were also linked to PVs. '&"
They appear to undergo self regression only rarely and have been described to progress ''"
occasionally into carcinomas (Smith et al. 2009). The involvement of a genetically and '("
serologically distinct equine PV EcPV2 has been suggested (O'Banion et al. 1986). The ')"
equine ear papillomas or aural papillomas have been described in horses of all ages (Scott and '*"
Miller 2003). Although they have a progressive character, progression into any cancer has not (+"
been reported. However, the involvement of a distinct PV in these lesions has been suggested (!"
(Fairley and Haines 1992, Scott and Miller 2003). (#"
 ($"
In order to identify, genetically characterize and compare viruses involved in the three (%"
described types of equine epithelial neoplasias, viral DNA derived from a penile papilloma (&"
and one derived from an aural papilloma was amplified, cloned and sequenced. Viruses ('"
termed EcPV2 and EcPV3 were identified. The genomes of the three EcPVs were found to (("
have certain similarities but nucleotide identities below the current definition of a genus. The ()"
suggested genetic distinctness of the viruses putatively involved in the three types of equine (*"
epithelial neoplasias could consequently be confirmed. )+"
 )!"
Materials and Methods: )#"
Samples  )$"
A 15 year old Icelandic horse (gelding) was presented with numerous white papules on the )%"
penis and preputium. Six-millimeter-punch biopsies were taken and histological examination )&"
revealed marked irregular hyperplasia with rete ridges and hypergranulosis with clumped )'"
  &"
keratohyalin granules. A marked loss of polarity was seen in the whole epidermis, especially )("
stratum spinosum. Koilocytes were not identified. A diagnosis of in situ carcinoma was made. ))"
A 7 year old Haflinger horse was presented with white, well demarcated papules from both )*"
lateral face of the pinnae. Eight-millimeter-punch biopsies were taken. Histological *+"
examination was carried out and revealed mild, papillated hyperplasia of the epidermis with *!"
marked orthokeratotic hyperkeratosis and clumped keratohyalin granues. Numerous swollen *#"
keratinocytes (koilocytes) with sometimes intranuclear inclusions were also noticed. A *$"
diagnosis of papillomavirus-induced equine ear papilloma was made. *%"
Samples for molecular-biological examination were stored at –20°C until processing. *&"
 *'"
Amplification and cloning of genomes *("
 Total DNA of 25 mg tissue sample was isolated using a DNeasy extraction kit (Qiagen) *)"
according to the manufacturer's recommendations. One microliter of the DNA extract was **"
then used for RCA (Rector 2004), using a TempliPhi Amplification kit (General Electrics !++"
Biosciences). Slight modifications were applied to the protocol supplied by the manufacturer: !+!"
1 !l of 10 mM dNTPs was added and the reaction time was prolonged to 16 h at 30°C. !+#"
Amplified DNA was cloned into the BamHI or EagI site of pBluescript II KS+ (Stratagene) in !+$"
case of isolate from the penile papilloma (EcPV2) and into the EcoRV, SpeI or the XbaI site !+%"
in case of the isolate from the aural plaques (EcPV3) using standard procedures. !+&"
 !+'"
Sequence analysis !+("
The nucleotide sequences of cloned DNA and of precipitated RCA product were determined !+)"
(Microsynth) by cycle sequencing using an ABI 377 sequencer (Applied Biosystems). !+*"
Positive and negative strand of one clone each were sequenced, in case of any doubts !!+"
precipitated RCA product was also sequenced for verification. Manual primerwalking !!!"
  '"
technique with overlapping sequences was used. The primary sequences were assembled !!#"
using Contigexpress software (Vector NTI Informax).  !!$"
The coding sequences for the E1, E2, L2 and L1 proteins from fifty papillomaviruses !!%"
including EcPV1, EcPV2 and EcPV3 were translated and a multiple sequence alignment !!&"
(MSA) for each of the four set of protein sequences was performed using MAFFT (version !!'"
6.6.11b; blossum 62 matrix, maxiterate 1000, localpair; (Katoh and Toh 2008)). Aligned !!("
nucleotide sequences were produced by matching the coding sequences with the !!)"
corresponding aligned protein sequences. The four sets of aligned nucleotide sequences !!*"
representing the four sets of protein sequences were combined to a single MSA by !#+"
concatenating the sequences from each virus. The resulting single MSA, 9504 nucleotide !#!"
positions in length, was then shortened to 4948 nucleotide positions by using GBLOCK !##"
(version 0.91b; half gap positions allowed; (Castresana 2000)). The optimal model of DNA !#$"
evolution was evaluated for best fit of the data set using MODELTEST (version 1.4.4; default !#%"
settings; (Posada and Crandall 1998)). Bayesian phylogeny was inferred using MRBAYES !#&"
(version 3.1.2; Markov Chain Monte Carlo with GTR substitution matrix, variable gamma !#'"
rates, invariant sites, 2 runs with 4 chains of ~3’700’000 generations; (Ronquist and !#("
Huelsenbeck 2003)). Evaluation of the MCMC and final refinement of the tree were !#)"
performed with BEAST (version 1.4.8; (Drummond and Rambaut 2007)). Pairwise !#*"
alignments were made in NEEDLE (EMBOSS) using the EDNAFULL matrix with a gap !$+"
penalty of 10.0 and a extend penalty of 0.1. The nucleotide sequence data of the PVs were !$!"
deposited in GenBank under accession numbers HM461973 (EcPV2) and GU384895 !$#"
(EcPV3). !$$"
 !$%"
  ("
Results !$&"
Genome and Open Reading Frames !$'"
The genome size of PVs ranges roughly from 7 to 8.6 kilobasepairs (kb) and a genomic !$("
organization containing typically seven or eight open reading frames (ORFs) as well as one or !$)"
two non-coding-regions (NCRs) (Howley and Lowy 2007). The genome size of novel EcPV3 !$*"
was determined as 7582 basepairs, which is similar to the other EcPVs as it is just slightly !%+"
less than EcPV1 (7610), whereas the EcPV2 isolate has 7803 basepairs. The GC contents are !%!"
51% for the EcPV3 genome, 56% for EcPV2 genome, and 53% for the EcPV1 genome. In all !%#"
the EcPV genomes, seven characteristic ORFs can be identified (Fig. 1). While the sizes of !%$"
the ORFs encoding for the late genes appear to be quite conserved, differences can be !%%"
observed among the early genes E6 and E7. The sizes of the two ORFs do not differ much in !%&"
EcPV1 and EcPV3 but are larger in case of the EcPV2 isolate. The E4 ORF which usually !%'"
lacks an own start codon varies also between the viruses, and therefore can not be predicted !%("
with certainty. !%)"
 !%*"
Characteristic motifs !&+"
Several characteristic features on the nucleotide and amino acid level have been identified, !&!"
which are predicted to play a role in the PV life cycle (Androphy et al. 1987, Wilson et al. !&#"
2002, Münger et al. 2004, Howley and Lowy 2007). The three EcPVs were scanned to !&$"
identify these putative sites and the analysis revealed typical features in the genomes of all of !&%"
them. Dyad symmetry repeats flanked by putative E2 binding sites, several more putative E2 !&&"
binding sites and at least one poly adenylation signal are present in every EcPV (Tab. 1). SP1, !&'"
NF1 and AP1 binding sites could be predicted in all three EcPVs but a classical TATA box is !&("
missing in EcPV2 (Tab. 1). Examination of the putative protein sequences reveal an ATP-!&)"
  )"
dependent helicase motif located in each E1 and two or one metal-binding motifs in E6 and !&*"
E7, respectively (Tab. 1). No putative pRB binding site (LXCXE) could be identified in any !'+"
of the EcPV E7 amino acid sequences. !'!"
 !'#"
Sequence analysis and comparison !'$"
In order to possibly allocate the novel PV, phylogeny based on the aligned E1-E2-L2-L1 !'%"
sequences was determined. Sequences of fifty PVs, representing all presently classified !'&"
genera including those of the three EcPVs were aligned (Fig. 2). Based on the resulting tree, !''"
the three viruses originally extracted from horses EcPV1, EcPV2, and EcPV3 were found to !'("
cluster together. They were allocated in relative vicinity of Chi, Dyotheta, Rho and Psi PV !')"
genera.   !'*"
In order to investigate the relatedness of the novel PV isolates according to the present !(+"
guidelines of PV classification (de Villiers et al. 2004, Bernard et al. 2010), pairwise !(!"
alignments were performed based on the nucleotide sequences. In case of the L1 ORF, which !(#"
is currently used for classification, EcPV1 was found to share 54.9% identities with the !($"
EcPV2 isolate and 53.2% with EcPV3, while the EcPV2 isolate shares 51.3% identities with !(%"
EcPV3. EcPV1 and EcPV2 are therefore the closest to each other among the tested sequences, !(&"
while the closest known relative to EcPV3 is the sequence of EcPV1. The other ORFs of the !('"
EcPVs were also compared by pairwise alignments. In case of E1, as the second ORF being !(("
relatively conserved, EcPV1 was found to share 53.4% identities with the EcPV2 isolate and !()"
56% with EcPV3, the EcPV2 isolate and EcPV3 share 48.8% identities with each other. !(*"
Among the other ORFs, identities between EcPVs were all between 39.5% and 46.4%. !)+"
 !)!"
  *"
Associated clinical conditions !)#"
The association of PVs with certain clinical signs is of special interest. The sequence of !)$"
EcPV1 has been obtained from cutaneous papillomas affecting the muzzle of horses and is !)%"
characterized as being typically associated with transient papillomas in horses younger than !)&"
three years of age (O'Banion et al. 1986, Scott and Miller 2003). The sequence of EcPV2 was !)'"
isolated from a penile papilloma and has repeatedly been detected in genital neoplasias !)("
(unpublished data). EcPV3 as described here was found in aural plaques of a horse. The three !))"
mentioned clinical conditions have been referred to be equine epithelial neoplasias in which a !)*"
papillomavirus involvement had been previously demonstrated or suggested (Scott and Miller !*+"
2003). !*!"
 !*#"
Discussion !*$"
PVs have been found in a large genetic variety in humans and in increasing numbers in !*%"
various other mammalian species. Their association with various diseases was demonstrated !*&"
or suggested and certain types of PVs seem to be responsible for distinct pathologies. In !*'"
horses, three epithelial neoplasias have been described and the question of PV involvement !*("
was previously addressed by various methods (O'Banion et al. 1986, Fairley and Haines 1992, !*)"
Ghim et al. 2004, Smith et al. 2009). It was concluded from the results, that classical equine !**"
viral papillomas, genital papillomas and equine ear papillomas are induced by different PVs #++"
(Scott and Miller 2003). As the classical equine viral papilloma associated EcPV1 was so far #+!"
the only equine PV characterized in more detail, our focus was on genital papillomas and #+#"
equine ear papillomas. The presented finding of DNA belonging to two distinct PVs other #+$"
than EcPV1 supports the hypothesis of three completely independent pathologies. Only one #+%"
case involving each PV was included here, so further research is needed to corroborate a #+&"
potential causative association between the viruses and the diseases. However, we have #+'"
  !+"
detected by PCR EcPV2 DNA in association with numerous cases of penile papilloma (data #+("
not shown), which supports the association with EcPV2 with this condition. Unfortunately, no #+)"
further cases of aural papillomas were available for analyses. Although further evidence will #+*"
be needed, this does not eliminate the fact that a thus far not described PV has been detected #!+"
in the context of this condition. The distinct nucleotide sequences of the three EcPVs goes in #!!"
line with the difference in the supposed course of infection leading to transient infections in #!#"
young animals in case of EcPV1, or to persistent or even progressing lesions on the genital #!$"
mucous membranes in case of EcPV2 and at the ear in case of EcPV3. The precise #!%"
mechanisms remain nevertheless unclear at this point. An important set of experiments to #!&"
address this issue will include analysis of viral gene expression within the lesions. However, #!'"
either RNA-preserving samples or specific antibodies against the viral gene products should #!("
be available for that purpose.  #!)"
The genomic organization of the three EcPVs is relatively similar containing the classical #!*"
ORFs E6, E7, E1, E2, E4, L2 and L1 as well as a large NCR. The length of the individual ##+"
ORFs was not found to vary significantly, except for E7 and to less extend E6. In case of ##!"
EcPV2 we decided to annotate the E6 by using the second start codon as putative start. We ###"
did so because alignments with other E6 sequences did not reveal any homologies in first part ##$"
of the putative long E6 ORF.  ##%"
 ##&"
Comparison of the novel sequences with the GenBank database revealed that a sequence of an ##'"
EcPV2 already exists in the database, supposedly deriving also from a genital neoplasia in a ##("
horse (NC_012123). This sequence is one nucleotide shorter, and annotated in a slightly ##)"
different way. The major difference between our sequence and this published one is the E1 ##*"
ORF which is significantly longer in case of the novel isolate.  #$+"
 #$!"
  !!"
The alignment of the L1 ORF has revealed identities clearly below 60%, allocating each of #$#"
the three EcPVs to a separate genus, Zeta and Dyoiota in case of EcPV1 and EcPV2 while #$$"
EcPV3 remains yet unclassified. As the novel isolate of EcPV2 shares 98.8% identities with #$%"
the sequence present in GeneBank in the L1 ORF, we may, according to the guidelines for #$&"
classification (de Villiers et al. 2004), be facing variants of the same virus. In a strict sense, #$'"
L1 is perceived as the single most important gene to be used for PV classification (de Villiers #$("
et al. 2004, Bernard et al. 2010). However, it has been shown that it is of advantage to include #$)"
the conserved regions of further ORFs into the phylogenetic analysis, especially when #$*"
relatively distant PVs are to be compared (Garcia-Valle et al. 2005, Erdélyi et al. 2008, #%+"
Stevens et al. 2010). Therefore, we chose to use the latter strategy for generating the #%!"
phylogenetic tree presented here.  #%#"
It is interesting to find the three EcPVs to cluster quite well upon phylogenetic analysis, while #%$"
the PV genera of other species appear rather scattered. The most likely explanation is though, #%%"
that we still have far too few PV sequences available to elucidate the phylogenetic relations #%&"
being well supported over all supertaxa and genera. #%'"
The finding of the novel EcPVs nevertheless helps to improve our understanding of PV #%("
phylogeny on the one hand and our interpretation of described pathologies on the other hand. #%)"
More details about the epidemiology and the molecular mechanisms of the discovered and yet #%*"
uncovered EcPVs will be needed to clarify our picture about PV associated epithelial #&+"
neoplasias. #&!"
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Figure captions: $#)"
Figure 1: Schematic presentation of the equine papillomavirus genomes and open reading $#*"
frames (ORFs). Genomes are divided into sections: early genes (Early), late genes (Late) and $$+"
non-coding regions (NCRs). Numbers indicate nucleotide positions. Nucleotide position $$!"
number one is defined here as the first following the stop codon of the L1 ORFs. $$#"
Figure 2: Bayesian phylogenetic tree of 50 papillomaviruses (PVs). The PV-types (with $$$"
GenBank accession numbers) included are: Alces alces: AaPV1 (M15953), bovine: BPV1 $$%"
(X02346), BPV3 (NC_004197), BPV4 (X05817), BPV5 (AF457465), BPV7 (NC_007612), $$&"
BPV8 (NC_009752), Capreolus capreolus: CcaPV1 (NC_011051), Caretta caretta: CcPV1 $$'"
(EU493092), Capra hircus: ChPV1 (NC_008032), canine: CPV1 (L22695), CPV2 $$("
(AY722648), CPV3 (NC_008297), CPV4 (NC_010226), Equus caballus: EcPV1 $$)"
(AF498323), EcPV2 (HM461973), EcPV3 (GU384895), Erethizon dorsatum: EdPV1 $$*"
(NC_006951), Erinaceus europaeus: EePV1 (EF396272), Fringilla coelebs: FcPV1 $%+"
(NC_004068), Felis domesticus:  FdPV1 (NC_004765), FdPV2 (EU796884), Francolinus $%!"
leucoscepus: FlPV1 (EU188799), human: HPV1 (NC_001356), HPV4 (NC_001457), HPV5 $%#"
(NC_001531), HPV9 (NC_001596), HPV16 (FJ610146), HPV18 (NC_001357), HPV32 $%$"
(NC_001586), HPV41 (NC_001354), HPV50 (NC_001691), HPV63 (NC_001458), $%%"
Mesocricetus auratus: MaPV1 (E15111), Micromys minutus: MmiPV1 (DQ269468), $%&"
Mastomys natalensis: MnPV1 (NC_001605), Ovis aries: OaPV1 (NC_001789), OaPV2 $%'"
(U83595), Oryctolagus cuniculus: OcPV1 (NC_002232), Odocoileus virginianus: OvPV1 $%("
(NC_001523), Psittacus erithacus: PePV1 (NC_003973), Phocoena spinipinnis: PsPV1 $%)"
(NC_003348), Rousettus aeyptiacus: RaPV1 (NC_008298), Rangifer tarandus: RtPV1 $%*"
(AF443292), Sylvilagus floridanus: SfPV1 (NC_001541), Sus scrofa: SsPV1 (NC_011280), $&+"
Trichechus manatus: TmPV1 (NC_006563), Tursiops truncatus: TtPV1 (EU240894), TtPV2 $&!"
(NC008184), Ursus maritimus: UmPV1 (NC_010739). Numbers at internal nodes represent $&#"
the posterior probability support values. Unclassified PVs are marked with an asterisk. $&$"
Table 1 
Characteristic features on nucleotide and amino acid level 
 
A 
Predicted nt-feature 
 
EcPV1 EcPV2 EcPV3 
E2 binding site 
(ACC-N5-7-GGT) 
116; 3028, 4168; 5298; 
5388; 6527; 7144; 7378; 
7509 
 
318; 4828; 5193; 7591; 7760 358; 650; 1148; 4142; 4226; 
5001; 6988; 7004; 7124; 
7218; 7310; 7337: 7468 
 
Dyad symmetry repeats * 
(TTGTTGTTAACAACAA) 
7550  (2) 145  ( 3) 7510  ( 2) 
Poly adanylation sites 
(AATAAA) 
2255; 3749; 3756; 6882 7216 2345; 6748; 6808 
SP1 binding sites 
(GGCGGG) 
3815; 3997; 4558; 5982; 
7357 
4707; 4929; 5180; 6723; 
7788 
1915; 4272; 4311; 4798; 
6967 
NF1 binding sites 
(CGGAA) 
483; 3329 2906; 3304; 3421; 3575; 
3895; 5435 
361; 687; 2946; 5591 
AP1 binding site 
(TGANTCA) 
3390; 4902 97 7459 
Tata signals 
(TATAAA or 
TATA(A/T)A(A/T)) 
6049; 6051; 7600 - 1563; 6547; 6827 
 
* Modified in all cases in 2 or 3 positions 
Underlined starting positions are part of the putative origin of replication 
 
B 
Predicted aa-feature 
 
EcPV1 EcPV2 EcPV3 
ATP-dependent helicase motifs 
in E1 (GPPNTGKS) 
443aa/2016nt 455aa/2305nt 443aa/2028nt 
metal-binding motifs in E6 
(CX2CX28-30CX2C) 
12aa/58nt; 85aa/277nt 8aa/260; 83aa/485nt 21aa/64nt; 94aa/283nt 
metal-binding motifs in E7 
(CX2CX28-30CX2C) 
53aa/508nt 70aa/813nt 47aa/572nt 
Leucine zipper domain in E1 
(LX5-7 LX5-7 LX5-7L) 
- - 264aa/1491nt 
Leucine zipper domain in E2 
(LX5-7 LX5-7 LX5-7L) 
- 4aa/2777nt - 
 
	  
